Cavion, Inc.
5Patents
5Active
5Granted
44Portfolio score
Filing activity: Oct 24, 2016 → May 6, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11311522B1 | Treating essential tremor using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide | Human Necessities | 1 | Active |
| US11130750B2 | Calcium channel inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11273218B2 | Methods for treating Angelman syndrome and related disorders | Human Necessities | 0 | Active |
| US12383539B2 | Treating essential tremor using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)pyridin-2-yl)ethyl)acetamide | Human Necessities | 0 | Active |
| US11324733B2 | Methods for improving memory and cognition and for treating memory and cognitive disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.